Artificial Intelligence in Clinical Trial will open new avenues for pharmaceutical companies. IBM Watson Health’s Clinical Trials Matching (CTM) is a system that is trained to abstract patient- and clinical trial-specific data from a variety of sources and harnesses machine learning to find clinical trials that are appropriate for a given patient.
Of the 2637 clinical trial matches made by CTM, 1818 (69%) were validated by clinical trial coordinators and sent to treating oncologists during the 6-month study period.
Artificial Intelligence in Clinical Trial can help to adjust in real-time the results  for the number of active clinical trials available in the 6 months preceding and 6 months following the introduction of CTM, clinical trial enrollment increased from 0.061 patients/trial to 0.097 patients/trial, representing an enrollment increase of approximately 59%.
BM Watson Health’s Clinical Trials Matching (CTM) system with screening coordinators facilitated an increase in clinical trial enrollment and promoted awareness of clinical trial opportunities within the lung oncology practice